Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-01

Clinical Trial Update: Non-Invasive Quantification of Liver Health in NASH (N-QUAN) [NA]

View source ↗

Summary

The N-QUAN trial, evaluating non-invasive quantification of liver health in nonalcoholic steatohepatitis (NASH), is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Perspectum | Conditions: NASH - Nonalcoholic Steatohepatitis | NA | Status: RECRUITING